2 months ago
Hyderābād, IndiaSenior
Responsibilities
- Design, configure, customize, and implement PLM solutions using 3DEXPERIENCE capabilities and enterprise integrations.
- Write clean, efficient, and well-tested code and participate in code reviews.
- Develop Python solutions for data migration and integration with enterprise systems.
- Create integrations using Enterprise Integration Framework with Veeva Vault, SAP, and MES systems.
- Configure and support Requirements, CAD, Risk, EBOM, MBOM, Configuration/Variants, Recipe, MPP, Document, and Change Management capabilities.
- Translate business requirements into technical solutions in collaboration with product owners, service owners, and delivery teams.
- Support software configuration propagation across tenants and ensure alignment with compliance and regulatory requirements.
- Collaborate with globally distributed technical, business, validation, and delivery teams.
- Provide technology education and support to new team members.
Requirements
- Bachelor’s or master’s degree in Business, Engineering, IT, or a related field.
- 5–8 years of experience in Business, Engineering, IT, or a related field.
- Hands-on experience with ENOVIA, DELMIA, CATIA Report Generator, NETVIBES, EKL, and OTScript in a Cloud SaaS environment.
- Experience configuring and customizing PLM solutions for Requirements, CAD, Risk, EBOM, MBOM, Configuration/Variants, Recipe, MPP, Document, and Change Management.
- Experience developing Python solutions for data migration and enterprise integration.
- Experience using Enterprise Integration Framework and middleware such as Mulesoft, Boomi, or Tibco.
- Experience with Git and GitLab.
- Experience supporting GMP applications across Engineering, Clinical, Commercial, and Quality functions.
- Understanding of the software development lifecycle and Scaled Agile practices, with SAFe for Teams certification preferred.
- Strong collaboration, communication, analytical, troubleshooting, leadership, and stakeholder-management skills.
About Amgen
Amgen is a public biotechnology company that discovers, develops, manufactures, and sells biologic and biosimilar therapeutics for patients with serious diseases. Its portfolio and pipeline span oncology, cardiovascular disease, osteoporosis, inflammation, and rare diseases, marketed globally through direct sales and partnerships. Founded in 1980 and headquartered in Thousand Oaks, California (NASDAQ: AMGN), Amgen is a component of the Dow Jones Industrial Average and completed the acquisition of Horizon Therapeutics in 2023.